Expanding Infrastructure Investments
Upgraded Samut Prakan Facility
Zuellig Pharma, a leading healthcare solutions provider in Asia, is reinforcing its commitment to Thailand with a 130 million baht investment in its Samut Prakan distribution center, announced on July 18, 2025. The upgraded facility, boasting 1,800-pallet storage and an ultra-low temperature freezer (-20°C to -30°C), supports the delivery of high-value, temperature-sensitive medicines. This expansion enhances Thailand’s capacity to handle advanced therapies, ensuring reliable access to critical healthcare solutions nationwide.
Driving Innovation Through Partnerships
Collaborations with Global Biopharma
To address Thailand’s aging population and rising chronic disease rates, Zuellig Pharma is forging strategic alliances with global biopharmaceutical firms. These partnerships accelerate the introduction of innovative treatments for complex conditions, such as weight-related disorders and chronic illnesses. By connecting healthcare providers with cutting-edge therapies, the company empowers professionals with essential tools and expertise, strengthening Thailand’s healthcare ecosystem and improving patient outcomes.
Enhancing Last-Mile Delivery
Sustainable and Secure Logistics
The revamped Samut Prakan center features advanced temperature controls, fire protection systems, and eco-friendly packaging like the eZCooler, ensuring safe delivery of medicines to remote communities. These upgrades reflect Zuellig Pharma’s focus on sustainability and safety in its supply chain. With automated defrost systems and robust logistics, the company ensures that even the most isolated regions of Thailand have access to life-saving medications and vaccines.
Supporting Communities Through Collaboration
Public-Private Partnerships
Zuellig Pharma’s partnerships with Thai institutions, such as Thammasat University Hospital, drive innovation and workforce development. Its collaboration with Action4Diabetes (A4D) since 2017 has provided logistics support for Type 1 diabetes care across Southeast Asia, including delivering care packs to Myanmar earthquake victims in March 2025 alongside City Love & Hope Foundation. These efforts highlight Zuellig’s role in bridging healthcare gaps and supporting vulnerable populations.
Proven Resilience in Crisis
COVID-19 Vaccine Distribution
During the COVID-19 pandemic, Zuellig Pharma played a pivotal role in Thailand by facilitating the distribution of millions of vaccine doses nationwide. This demonstrated its logistical agility and commitment to public health during crises. By leveraging its extensive distribution network, the company ensured timely access to critical vaccines, reinforcing its position as a trusted partner in Thailand’s healthcare system.
Strategic Vision for Regional Growth
Thailand as a Healthcare Hub
John Graham, Group CEO of Zuellig Pharma, emphasized Thailand’s pivotal role in the company’s ASEAN strategy, citing its progressive regulations and talent pool. “Our investments reflect confidence in Thailand’s potential to shape regional healthcare,” he said. With over 75 years in Thailand, Zuellig Pharma’s focus on sustainable innovation and equitable access positions it to meet the challenges of an aging population and growing demand for advanced therapies, ensuring no patient is left behind.
